{"id":87163,"date":"2023-11-24T17:20:02","date_gmt":"2023-11-24T17:20:02","guid":{"rendered":"https:\/\/www.atlasrleye.com\/proliferative-diabetic-retinopathy-in-type-2-diabetes\/clinical-case-2\/"},"modified":"2024-02-28T22:56:38","modified_gmt":"2024-02-28T22:56:38","slug":"clinical-case-2","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/proliferative-diabetic-retinopathy-in-type-2-diabetes\/clinical-case-2\/","title":{"rendered":"Clinical Case 2"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 2 Diabetes – Clinical Case 02″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-2-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%202%20DIABETES|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\"\"Fundus photograph of proliferative diabetic retinopathy in a 66-years-old male patient with the diagnosis of diabetes since 5 years ago. Note the neovascularization of the optic disc and minimal hemovitreous.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”62312″ img_size=”270×270″ alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Ultra-widefield photograph magnification of posterior pole in same case, 3 years later. Visual acuity: 20\/200 LE.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 06 07 2005″ tab_id=”1641394922374-47016b7f-6668″][vc_row_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Hyperfluorescent microaneurysms.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62222″ img_size=”275*206″ css=”.vc_custom_1708375892411{margin-top: -30px !important;}”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62219″ img_size=”210*206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Proliferative diabetic retinopathy in a 64-years-old male patient with diabetes diagnosed 3 years ago.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62216″ img_size=”251×206″ css=”.vc_custom_1708375784203{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – 19 12 2007″ tab_id=”1661785499295-37aad728-7a9d”][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Leakage at the optic disc.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62234″ img_size=”206×206″ css=”.vc_custom_1708375952707{margin-top: -30px !important;}”][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62231″ img_size=”210×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Neovascularization of the optic disc and minimal vitreous hemorrhage.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62228″ img_size=”251×206″ css=”.vc_custom_1708375912411{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62237,62225″ img_size=”224*110″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – postoperative – 22 09 2009″ tab_id=”1661785585289-ac6c19a9-e70f”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Two days after surgery.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62240,62252″ img_size=”323×206″ css=”.vc_custom_1708376031918{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62249,62246″ img_size=”207×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Three months after surgery showing patches of emulsified silicone oil .<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62243″ img_size=”251×206″ css=”.vc_custom_1708376002204{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”4th Evaluation – 02 02 2011″ tab_id=”1661509875561-9afbb161-ae27″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

Severe cystoid macular edema.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62255,62261,62264,62276,62273″ img_size=”307×110″ css=”.vc_custom_1708376062275{margin-top: -30px !important;}”][vc_gallery type=”image_grid” images=”62258,62270,62267″ img_size=”207×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62291,62285,62282″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62279,62288″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”5th Evaluation – 17 03 2011″ tab_id=”1661785886686-d98df48a-eeb9″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

One week after intravitreal injection of dexamethasone implant. Note the reduction of cystoid macular edema and an epiretinal membrane causing foveolar traction.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62297,62303,62300,62306″ img_size=”307×110″ css=”.vc_custom_1708376088763{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62318″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/2″][vc_gallery type=”image_grid” images=”62315,62312″ img_size=”251×250″][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_gallery type=”image_grid” images=”62309,62294″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”6th Evaluation – 30 06 2011″ tab_id=”1661528679639-01942171-9860″][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62342″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62324″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62321″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62330,62327,62333,62336″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Laser scars and some areas of chorioretinal atrophy. Visual acuity: 20\/100 LE. HbA1c=6,1%. BP=137\/79 mmHg.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62339,62345″ img_size=”251×206″ css=”.vc_custom_1708376121086{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”7th Evaluation – 17 04 2013″ tab_id=”1661786157698-46eebd5b-a2a4″][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62369″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62351″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62348″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62375,62354,62360,62357″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

VA: 20\/60 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62366,62372,62363″ img_size=”251×206″ css=”.vc_custom_1708376149179{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”8th Evaluation – 03 07 2019″ tab_id=”1709159748749-ba616f93-93a3″][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99448″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99444″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99476″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

VA: 20\/100c LE. Calcium phosphate deposits on the surface of the intraocular lens.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99468″ img_size=”300×206″ css=”.vc_custom_1709159921522{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99452,99456,99460,99464″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99472″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p><\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 2 Diabetes – Clinical Case 02″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-2-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%202%20DIABETES|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text] Fundus photograph of proliferative […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":75341,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-87163","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=87163"}],"version-history":[{"count":22,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87163\/revisions"}],"predecessor-version":[{"id":99824,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87163\/revisions\/99824"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75341"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=87163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}